at-home COVID-19 testing

Cue Health reader with red background
Cue Health receives first-ever de novo authorization for at-home COVID-19 test
By Jessica Hagen | 01:00 pm | June 08, 2023
The company was also the first to receive emergency use authorization for its home COVID-19 test in 2021.
A man using the Detect COVID-19 test
Detect scores EUA from FDA for at-home molecular COVID-19 test
By Emily Olsen | 03:20 pm | October 29, 2021
Detect uses an app to help users perform the test and interpret the results.
A person receiving a vaccine
Sprinter Health scores $33M for its in-home lab service
By Emily Olsen | 02:12 pm | October 13, 2021
Sprinter sends nurses and phlebotomists into the home to collect for lab tests, do vitals checks and test for COVID-19.
DOC2US releases smart COVID-19 rapid test system
By Adam Ang | 02:59 am | July 27, 2021
The diagnostic system enables self-testing and uses AI to prevent fraudulent results.
Everlywell forms new at-home lab testing subsidiary through PWNHealth purchase
By Mallory Hackett | 01:17 pm | March 24, 2021
PWNHealth will rebrand as Everly Health Solutions and will operate as an independent arm of Everly Health.
Truepill rolls out suite of COVID-19 diagnostics, digital tools for the employer market
By Laura Lovett | 11:23 am | March 11, 2021
Truepill inked a deal with Health Transformation Alliance in order to offer its new services to the latter's members. 
FDA gives Cue Health first EUA for at-home, OTC COVID-19 molecular testing
By Dave Muoio | 05:36 pm | March 05, 2021
The system delivers its results to a companion app in about 20 minutes, according to the agency.
Everlywell caps off a busy year for home health testing with $175M Series D
By Dave Muoio | 01:12 pm | December 03, 2020
The company projects that sales of its testing kits will triple by the end of 2020.
New COVID-19 technology offers pooled screening for large groups
By Sara Mageit | 10:23 am | November 24, 2020
The technology will be able to screen up to 40 people at once.
FDA authorizes first COVID-19 test for self-testing at home
By Dave Muoio | 01:29 pm | November 18, 2020
Lucira's molecular testing kit allows individuals to collect their own nasal sample and insert it into a device that provides results in under 30 minutes. The company is aiming to sell the single-use tests for roughly $50.